These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 27221823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH, Kim P, Nesheim ME.
    J Biol Chem; 2008 Apr 04; 283(14):8863-7. PubMed ID: 18252711
    [Abstract] [Full Text] [Related]

  • 6. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ.
    J Thromb Haemost; 2016 Aug 04; 14(8):1629-38. PubMed ID: 27279497
    [Abstract] [Full Text] [Related]

  • 7. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME.
    J Biol Chem; 1998 Oct 16; 273(42):27176-81. PubMed ID: 9765237
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO.
    J Biol Chem; 2011 Jan 07; 286(1):502-10. PubMed ID: 21041299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor.
    Marx PF, Havik SR, Marquart JA, Bouma BN, Meijers JC.
    J Biol Chem; 2004 Feb 20; 279(8):6620-8. PubMed ID: 14660622
    [Abstract] [Full Text] [Related]

  • 14. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L, Jain N, Wang P, Walker JB.
    Crit Care Med; 2004 May 20; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [Abstract] [Full Text] [Related]

  • 15. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA, Poolen GC, Koekman CA, Verhoef S, de Maat S, Barendrecht A, van Kleef ND, Meijers JCM, Schiffelers RM, Maas C, Urbanus RT.
    J Thromb Haemost; 2022 May 20; 20(5):1213-1222. PubMed ID: 35170225
    [Abstract] [Full Text] [Related]

  • 16. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.
    Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M.
    J Biol Chem; 2002 Jan 11; 277(2):1021-30. PubMed ID: 11684677
    [Abstract] [Full Text] [Related]

  • 17. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN, Meijers JC.
    J Thromb Haemost; 2003 Jul 11; 1(7):1566-74. PubMed ID: 12871292
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.